MFC51123

MFC51123 · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MFC51123, covering 2017-06-28 to 2017-06-28. Get the full timeline:

Most recent: Clinical Trial Update: A Safety Study to Investigate the Skin Sensitization Potential of MFC51123 [Phase 1]